SMC completes initial assessment of evidence for volanesorsen sodium
From 16 November 2020, volanesorsen can be prescribed within the ultra-orphan pathway while further evidence on its effectiveness is generated to allow a decision on its routine use in NHS Scotland.
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date